BHC

Conviction 49HealthcareScan · Mon, Aug 10, 2026

Shooting star

BHC$6.34+1.44%

ResistanceSupportVol 14Insider sell

Vol MA14 6.76M

May 11May 28Jun 16Jul 6Jul 23Aug 10

Bausch Health Companies Inc.PHARMACEUTICAL PREPARATIONSwww.bauschhealth.com ↗

Price6.34

Change+1.44%

Gap+0.00%

Rel volume0.72×

Avg volume5.33M

Avg $ vol32.51M

SMA 205.34

SMA 505.13

SMA 2005.85

Price vs 50+23.67%

Price vs 200+8.37%

MA stackmixed

50/200 cross—

Supertrendup · 5.69

RSI (14)63

MACD hist0.13

MACD crossbull · 7d

Stoch %K / %D67 / 62

ADX (14)33

+DI / −DI42 / 16

RSI divergence—

MACD divergence—

ATR %+6.03%

ADR %5.97%

52w high8.34

52w low4.43

From 52w high-23.98%

Above 52w low+43.12%

New 52w highNo

SqueezeOff

Bollinger width67.08%

%B0.78

Donchian pos67.68%

Donchian high7.30

Donchian low4.33

AVWAP (52w high)6.15

vs AVWAP high+3.12%

AVWAP (52w low)6.10

vs AVWAP low+3.99%

OBV trendUp

Chaikin MF (20)0.21

Today vs 20d0.72×

Avg vol (14d)6.76M

Avg vol (20d)5.33M

Avg $ vol (20d)32.51M

Market cap2.37B

RS 3m (vs SPY)+3.38%

RS 6m (vs SPY)-5.04%

RS line new highNo

Trend template5/8

Technical rank72.4

1 week-9.43%

1 month+32.64%

3 months+10.26%

6 months+7.82%

1 year+10.07%

YTD-12.07%

P/E15.10

P/B-1.34

P/S0.23

P/FCF2.36

EPS0.4200

Div yield15.03%

ROE-8.87%

ROA0.63%

Debt/Eq-11.71

Current1.44

EV/EBITDA7.05

Gross margin—

Net margin1.53%

Rev growth6.66%

EPS growth441.30%

Price target8.00

Target upside26.18%

Analyst ratingHold

Institutional67.54%

Ent. value21.29B

Revenue2.85B

Net income258M

Gross profit—

Free cash flow1B

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNYSE

Shares out374.02M

Employees20.3K

ListedThu, Mar 31, 1994

Free float262.07M

Float %70.3%

Short interest7.37M

Days to cover3.7d

Short volume33.9%

Squeeze score24 / 100

Next earnings—

EPS forecast—

Last EPS vs est$1.26 vs $0.96

Last surprise+31.3% beat

Setup gradeC

Conviction49 / 100

Pattern quality—

Tech rank72.4 / 100

Group rank86 / 100 · Leading

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmShooting star

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in BHC

All disclosures →

No recent disclosed trades by Congress in BHC. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in BHC · 7 buys · 2 sells

Insider	Side	Shares	Value	Traded	Filed
Lenar Aimee J. President, US Pharma · Common Shares, No Par Value · 2026-07-15	Tax	23.39K	$114K	2026-07-15	2026-07-17
LEE STEVEN HYOSIG SVP, Controller & CAO · Common Shares, No Par Value · 2026-07-14	Tax	3.13K	$15K	2026-07-14	2026-07-15
LEUNG SANDRA Director · Common Shares, No Par Value · 2026-05-22	Grant	45.87K	$0	2026-05-22	2026-05-26
Garcia Christian A Director · Common Shares, No Par Value · 2026-05-22	Grant	45.87K	$0	2026-05-22	2026-05-26
ROBERTS EIRY Director · Common Shares, No Par Value · 2026-05-22	Grant	45.87K	$0	2026-05-22	2026-05-26
Lee Frank D. Director · Common Shares, No Par Value · 2026-05-22	Grant	45.87K	$0	2026-05-22	2026-05-26
WECHSLER AMY B Director · Common Shares, No Par Value · 2026-05-22	Grant	45.87K	$0	2026-05-22	2026-05-26
Paulson John Director · Common Shares, No Par Value · 2026-05-22	Other	—	—	2026-05-22	2026-05-26
POWER ROBERT N Director · Common Shares, No Par Value · 2026-05-22	Grant	45.87K	$0	2026-05-22	2026-05-26
GOETTLER MICHAEL Director · Common Shares, No Par Value · 2026-05-22	Grant	45.87K	$0	2026-05-22	2026-05-26

SEC filings

EDGAR filings in BHC · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.